ST
BIO icon

Sageworth Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sageworth Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17
Closed -$8.14K – 124
2023
Q1 		$8.14K Buy
+17
New +$7.96K ﹤0.01% 311
2022
Q1 		– Sell
-18
Closed -$14K – 403
2021
Q4 		$14K Sell
18
-62
-78% -$46.4K ﹤0.01% 221
2021
Q3 		$60K Hold
80
– – ﹤0.01% 165
2021
Q2 		$52K Buy
+80
New +$48.7K ﹤0.01% 223

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Sageworth Trust's BIO Position: Q2 2023 in Review

Sageworth Trust sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 17 shares — an estimated $8.14K sold.

Sageworth Trust first reported a position in BIO in Q2 2021 and held it in 4 quarters. The position peaked at $60K in Q3 2021. 468 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Sageworth Trust reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Sageworth Trust sold 17 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $8.14K.
  • Sageworth Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and held it in 4 quarters.
  • Sageworth Trust's Bio-Rad Laboratories Class A position peaked at $60K in Q3 2021.
  • 468 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.